Valuation: Johnson & Johnson

Market Cap 640B 555B 523B 475B 891B 61,343B 897B 6,250B 2,409B 31,119B 2,404B 2,351B 98,934B P/E 2026 *
29.6x
P/E 2027 * 24.7x
Enterprise Value 665B 577B 544B 494B 926B 63,784B 933B 6,499B 2,504B 32,358B 2,499B 2,444B 102,870B EV / Sales 2026 *
6.57x
EV / Sales 2027 * 6.04x
Free-Float
77.16%
Yield 2026 *
2.02%
Yield 2027 * 2.11%
1 day+1.11%
1 week-3.24%
Current month+0.18%
1 month+2.29%
3 months+10.57%
6 months+10.27%
Current year+28.69%
1 week 265.25
Extreme 265.25
271.55
1 month 258.01
Extreme 258.01
281.07
Current year 200.91
Extreme 200.9101
281.07
1 year 173.33
Extreme 173.33
281.07
3 years 140.68
Extreme 140.68
281.07
5 years 140.68
Extreme 140.68
281.07
10 years 109.16
Extreme 109.16
281.07
Manager TitleAgeSince
Chief Executive Officer 63 02/01/2022
Director of Finance/CFO 59 30/06/2018
Chief Tech/Sci/R&D Officer 61 31/07/2024
Director TitleAgeSince
Director/Board Member 62 14/10/2013
Director/Board Member 71 08/06/2015
Chairman 63 01/01/2023
Date Insider Type Main position Quantity % Market Cap. Importance
08/09/26 Free

Director

136 0.0000%
08/09/26 Free

Director

181 0.0000%
08/09/26 Free

Director

113 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.28%-3.24%+49.57%+62.65% 640B
+2.02%-0.96%+50.69%+92.40% 994B
+1.81%+2.07%+19.89%+70.38% 454B
+5.00%+2.21%+36.64%+39.24% 337B
+1.68%-9.20%+15.25%+24.87% 261B
+3.81%+1.23%+3.05%+14.86% 246B
+1.10%-12.75%+38.03%+45.44% 204B
+1.43%-6.19%-19.49%-58.38% 190B
+1.87%-3.04%+27.81%+89.26% 178B
0.00%-2.57%+16.13%-18.83% 158B
Average +1.78%-4.77%+23.76%+36.19% 366.28B
Weighted average by Cap. +1.53%-3.72%+32.71%+54.18%

Financials

2026 *2027 *
Net sales 101B 87.76B 82.82B 75.14B 141B 9,708B 142B 989B 381B 4,925B 380B 372B 15,657B 109B 94.51B 89.19B 80.91B 152B 10,454B 153B 1,065B 410B 5,303B 410B 401B 16,860B
Net income - -
Net Debt 25.46B 22.07B 20.82B 18.89B 35.44B 2,441B 35.69B 249B 95.83B 1,238B 95.64B 93.54B 3,936B 19.16B 16.6B 15.67B 14.21B 26.66B 1,836B 26.85B 187B 72.1B 932B 71.96B 70.37B 2,961B
Logo Johnson & Johnson
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (64.1%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (35.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; At the end of 2025, Johnson & Johnson has 63 manufacturing facilities located in the United States (22), North America (7), Europe (22), Africa and Asia/Pacific (12). The United States accounts for 57.1% of net sales.
Employees
138,200
Date Price Change Volume
14/09/26 US$266.32 +0.28% 4,741,505
11/09/26 US$265.58 -0.29% 4,706,291
10/09/26 US$266.35 -0.27% 4,931,607
09/09/26 US$267.08 -0.76% 6,125,049
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
266.32USD
Average target price
277.91USD
Spread / Average Target
+4.35%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!